1.
Haifa Kathrin Al-Ali, Martin Griesshammer, Philipp le Coutre, Cornelius F. Waller, Anna Marina Liberati, Philippe Schafhausen, Renato Tavares, Pilar Giraldo, Lynda Foltz, Pia Raanani, Vikas Gupta, Bayane Tannir, Julian Perez Ronco, Jagannath Ghosh, Bruno Martino, Alessandro M. Vannucchi. Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial. haematol [Internet]. 2016Sep.1 [cited 2022Sep.28];101(9):1065-73. Available from: https://haematologica.org/article/view/7819